Prices are updated after-hours

Professional, Scientific, and Technical Services 2022 - 04 - 12

BriaCell Therapeutics Corp.

BCTX | $2.19 -5.6% -5.94% 140K

(0.0% 1d) (-3.2% 1m) (-61.3% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (NaN% volume)
Earnings Calendar:
Market Cap: $ 34,999,980
https://www.briacell.com
Sec Filling | Patents | 2022 employees

BriaCell is an immuno-oncology focused biotechnology company developing targeted and effective approaches for the management of cancer.

cancer

add to watch list Paper trade email alert is off

Value Exchange International, Inc.

VEII 4 | $0.061 238.89% 23K

Professional, Scientific, and T...

(0.0% 1d) (13.0% 1m) (69.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (282.64% volume)
Earnings Calendar:
Market Cap: $ 2,653,546

Sec Filling | Patents | 300 employees

processing over us$ 20 billion worth in annual payment transactions at over 30,000 point of sale terminals for over 120 merchants, vei is recognized as the number #1 cloud based customer relationship management (crm) software service provider in the asia-pacific (apac) region. we’ve worked with retailers like a.s. watson group, 7-eleven, walmart, robinsons retail group; and with top technology partners like fujitsu, retalix, tencent, asiapay and more, to make your shopping experience even better. vei can help you drive new revenues and monetize your network in new and profitable ways. as the industry leader in innovative and collaborative technology solutions, vei can help you drive new revenues and monetize your network in new and profitable ways. vei’s solutions, platforms, and technologies provide a scalable, standards-based intelligent architecture that enables you to integrate subscriber knowledge with network and application intelligence in real-time to offer an expanding portfol

profitable spac

add to watch list Paper trade email alert is off

UpHealth Inc

UPH | $0.3 9.13% 0.0% 350K

Professional, Scientific, and T...

(0.0% 1d) (0.0% 1m) (-81.9% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (3.3% volume)
Earnings Calendar: 2024-02-29
Market Cap: $ 5,332,649
https://www.gigcapital2.com
Sec Filling | Patents | 2 employees

(United States) GigCapital Global is a Private-to-Public Equity investment group, sponsoring and operating Special Purpose Acquisition Companies ('SPAC', also known as Blank-Check companies). Founded in 2017 by Dr. Avi Katz, the GigCapital Group and its sponsored SPACs are led by an affiliated team of technology industry experts, deploying a unique Mentor-Investors™ methodology to partner with exceptional privately-held and U.S. and non-U.S. public technology companies led by dedicated, innovative entrepreneurs. The GigCapital Group companies offer financial, operational and executive mentoring to U.S. and global private, and non-U.S. public companies, in order to accelerate their path from inception and as a privately-held entity into the growth-stage as a publicly traded company in the U.S. The partnership of the GigCapital Group with these companies continues through an organic and roll-up strategy growth post the transition to a public company.

msa acquisitions spac blank check

add to watch list Paper trade email alert is off

Zentek Ltd.

ZTEK | $1.14 1.33% 13K

Professional, Scientific, and T...

(0.0% 1d) (-12.3% 1m) (-26.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (37.21% volume)
Earnings Calendar: 2024-02-09
Market Cap: $ 114,934,318
https://zengraphene.com/
Sec Filling | Patents | n/a employees

(CA)

add to watch list Paper trade email alert is off

IonQ Inc

IONQ 4 | $7.49 5.64% 0.67% 5.6M

Professional, Scientific, and T...

(0.0% 1d) (-21.6% 1m) (28.3% 1y) (0.0% 2d) (0.0% 3d) (2.9% 7d) (26.59% volume)
Earnings Calendar:
Market Cap: $ 1,559,639,097
https://ionq.com
Sec Filling | Patents | n/a employees

IonQ, Inc. is a leader in quantum computing, with a proven track record of innovation and deployment. IonQ’s next-generation quantum computer is the world’s most powerful trapped-ion quantum computer, and IonQ has defined what it believes is the best path forward to scale. IonQ is the only company with its quantum systems available through the cloud on Amazon Braket, Microsoft Azure, and Google Cloud, as well as through direct API access. IonQ was founded in 2015 by Christopher Monroe and Jungsang Kim based on 25 years of pioneering research.

computational

add to watch list Paper trade email alert is off

ImmunoPrecise Antibodies Ltd

IPA | $1.25 -0.79% -1.2% 30K

Professional, Scientific, and T...

(0.0% 1d) (-17.8% 1m) (-58.9% 1y) (0.0% 2d) (0.0% 3d) (-1.6% 7d) (-80.09% volume)
Earnings Calendar: 2024-03-14
Market Cap: $ 32,894,075
http://www.immunoprecise.com/
Sec Filling | Patents | 2021 employees

(CA) IPA is an innovation-driven, technology platform company that supports its pharmaceutical and biotechnology company partners in their quest to discover and develop novel, therapeutic antibodies against all classes of disease targets. The Company aims to transform the conventional, multi-vendor, product development model by bringing innovative and high-throughput, data-driven technologies to its partners, incorporating the advantages of diverse antibody repertoires with the Company's therapeutic antibody discovery suite of technologies, to exploit antibodies of broad epitope coverage, multiple antibody formats, valency and size, and to discover antibodies against multiple/rare epitopes.

covid antibody

add to watch list Paper trade email alert is off

Mister Car Wash Inc

MCW 4 | $6.84 1.94% 1.02% 1.5M

Professional, Scientific, and T...

(0.0% 1d) (-7.6% 1m) (-20.7% 1y) (0.0% 2d) (0.0% 3d) (5.4% 7d) (25.61% volume)
Earnings Calendar: 2024-02-21
Market Cap: $ 2,173,991,961
https://mistercarwash.com
Sec Filling | Patents | 4625 employees

Headquartered in Tucson, Arizona, Mister Car Wash operates over 340 car washes nationwide. The Mister Car Wash brand is anchored in quality, friendliness and a commitment to creating memorable customer experiences. Mister Car Wash’s people are what make it successful and allow it to achieve these high standards. Mister Car Wash continues to focus on recruiting and retaining top talent, developing best-in-class training programs and investing in employee benefits to cultivate a positive company culture.

brands

add to watch list Paper trade email alert is off

OMNIQ Corp

OMQS | $0.4216 -4.25% -4.29% 160K

Professional, Scientific, and T...

(0.0% 1d) (-17.6% 1m) (-90.9% 1y) (0.0% 2d) (0.0% 3d) (-32.3% 7d) (-50.79% volume)
Earnings Calendar: 2023-11-13
Market Cap: $ 4,506,993
https://www.omniq.com
Sec Filling | Patents | 61 employees

OMNIQ Corp. provides computerized and machine vision image processing solutions that use patented and proprietary AI technology to deliver data collection, real-time surveillance and monitoring for supply chain management, homeland security, public safety, traffic & parking management and access control applications. The technology and services provided by the Company help clients move people, assets and data safely and securely through airports, warehouses, schools, national borders, and many other applications and environments. OMNIQ’s customers include government agencies and leading Fortune 500 companies from several sectors, including manufacturing, retail, distribution, food and beverage, transportation and logistics, healthcare, and oil, gas, and chemicals. Since 2014, annual revenues have grown to more than $50 million from clients in the USA and abroad. The Company currently addresses several billion-dollar markets, including the Global Safe City market, forecast to grow to $29 billion by 2022, and the Ticketless Safe Parking market, forecast to grow to $5.2 billion by 2023.

security

add to watch list Paper trade email alert is off

Recursion Pharmaceuticals Inc - Class A

RXRX | $7.6 3.4% 3.35% 3.4M

Professional, Scientific, and T...

(0.0% 1d) (-27.8% 1m) (40.7% 1y) (0.0% 2d) (0.0% 3d) (1.7% 7d) (-1.67% volume)
Earnings Calendar: 2024-02-26
Market Cap: $ 1,726,289,848
https://www.recursionpharma.com
Sec Filling | Patents | n/a employees

Recursion is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Central to its mission is the Recursion Operating System, or Recursion OS, that combines an advanced infrastructure layer to generate what Recursion believes is one of the world's largest and fastest-growing proprietary biological and chemical datasets and the Recursion Map, a suite of custom software, algorithms, and machine learning tools that the company uses to explore foundational biology unconstrained by human bias and navigate to new biological insights which may accelerate its programs. biotechnology company scaling more like a technology company.

drug discovery machine learning

add to watch list Paper trade email alert is off

Alzamend Neuro Inc

ALZN | $0.685 1.41% -0.23% 48K

Professional, Scientific, and T...

(0.0% 1d) (-31.7% 1m) (17.6% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (68.9% volume)
Earnings Calendar: 2024-03-14
Market Cap: $ 4,703,790
https://alzamend.com/
Sec Filling | Patents | 3 employees

(United States) Alzamend Neuro is a preclinical stage biopharmaceutical company focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer’s disease. With its product candidates, the company aims to bring treatments or cures to market at a reasonable cost as quickly as possible. Its current pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient’s immunological system to combat Alzheimer’s. Both of its product candidates are licensed from the University of South Florida Research Foundation, Inc. pursuant to royalty-bearing exclusive worldwide licenses.

treatment msa vaccine t-cell lithium alzheimer neurodegenerative alzheimer’s

add to watch list Paper trade email alert is off

Definitive Healthcare Corp.

DH | $7.33 3.82% 3.95% 1.1M

Professional, Scientific, and T...

(0.0% 1d) (-6.7% 1m) (-36.1% 1y) (0.0% 2d) (0.0% 3d) (3.8% 7d) (103.21% volume)
Earnings Calendar: 2024-02-28
Market Cap: $ 863,394,726
https://www.definitivehc.com
Sec Filling | Patents | 2021 employees

Definitive Healthcare transforms data, analytics and expertise into healthcare commercial intelligence. The company helps clients uncover the right markets, opportunities and people, so they can shape tomorrow’s healthcare industry. Its SaaS platform creates new paths to commercial success in the healthcare market, so companies can identify where to go next.

add to watch list Paper trade email alert is off

E-Home Household Service Holdings Ltd

EJH | $3.02 -3.67% -2.79% 3.8M

Professional, Scientific, and T...

(0.0% 1d) (127.1% 1m) (717.1% 1y) (0.0% 2d) (0.0% 3d) (-3.5% 7d) (102.76% volume)
Earnings Calendar:
Market Cap: $ 414,241,420

Sec Filling | Patents | n/a employees

add to watch list Paper trade email alert is off

BIOXYTRAN, INC

BIXT A | $0.141 6.42% 490.75% 55K

Professional, Scientific, and T...

(0.0% 1d) (27.2% 1m) (-70.5% 1y) (0.0% 2d) (0.0% 3d) (16.7% 7d) (-80.8% volume)
Earnings Calendar:
Market Cap: $ 24,531,466
https://www.bioxytraninc.com/
Sec Filling | Patents | 3 employees

(US) bioxytran, inc., an early stage pharmaceutical company, focuses on the development, manufacture, and commercialization of various therapeutic drugs to address hypoxia in humans. the company's lead pharmaceutical drug candidate is bxt-25, an oxygen-carrying small molecule consisting of bovine hemoglobin stabilized with a co-polymer for the treatment of patients with ischemia of the brain resulting from a stroke or the blockage of the blood vessels to the brain. its products also include bxt-252, an injectable anti-necrosis drug to treat a wound that does not heal because limited amount of oxygen reaching the wound. the company was founded in 2017 and is headquartered in newton, massachusetts.

injection

add to watch list Paper trade email alert is off